2023, Vol. 5, Issue 4, Part A

The purpose of the work: is determining the prevalence of IBS and its associated factors among CKD patients undergoing hemodialysis.

Method and materials: A cross-sectional research was conducted on a group of 200 patients who were receiving hemodialysis. The patients were categorized into two distinct groups: Group A: 100 patients of CKD on hemodialysis and Group B: 100 patients of CKD on non-hemodialysis treatment. All Patients diagnosed to have IBS in hemodialysis according to ROME IV criteria. The presence of depression and anxiety was assessed using the Hamilton Depression Rating Scale (HAM-D) and the Hamilton Anxiety Rating Scale (HAM-A).

Results: In our study IBS in hemodialysis group was significantly (59%) in comparison to non-hemodialysis CKD group was (44%). In this current study we had found depressive symptoms in a significant percentage of patients more than (64%) among those in dialysis and (47%) among those in non-hemodialysis CKD group. In our study, we had found anxiety symptoms in a significant percentage of patients more than (62%) among those in dialysis and (41%) among those in non-hemodialysis CKD group. Patients with IBS had substantially higher ratings for anxiety and sadness compared to those without IBS (p<0.029 and p<0.001, respectively).

Conclusion: Patients undergoing hemodialysis were more likely to have IBS, according to our research. A greater prevalence of depression and anxiety was observed as well in the hemodialysis group when contrasted with the non-hemodialysis CKD group.